Overview
CureDuchenne Ventures is a U.S.-based venture capital firm that provides equity funding to companies developing treatments and therapies for Duchenne muscular dystrophy. The firm invests in seed through Series B stage companies focused on advancing innovative solutions in the Duchenne space. CureDuchenne Ventures is part of the broader CureDuchenne organization's mission to accelerate research and drug development for this rare disease.
